Clearside Biomedical, Inc. (CLSDQ) — DEF 14A Filings
All DEF 14A filings from Clearside Biomedical, Inc.. Browse 3 Proxy Statement reports with AI-powered summaries and risk analysis.
DEF 14A Filings (3)
-
Clearside Biomedical Proposes 1-for-5 to 1-for-15 Reverse Stock Split
— Aug 4, 2025 Risk: high
Clearside Biomedical, Inc. (CLSDQ) is holding a Special Meeting of Stockholders on August 29, 2025, to approve a reverse stock split. The proposed reverse stock -
Clearside Biomedical Files 2024 Executive Compensation Details
— Apr 18, 2025 Risk: low
Clearside Biomedical, Inc. filed its DEF 14A on April 18, 2025, for the fiscal year ending December 31, 2024. The filing details executive compensation, includi -
Clearside Biomedical Files Definitive Proxy Statement
— Apr 26, 2024 Risk: low
Clearside Biomedical, Inc. (CLSDQ) filed a Proxy Statement (DEF 14A) with the SEC on April 26, 2024. Clearside Biomedical, Inc. filed a Definitive Proxy Stateme
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX